Surmodics | SRDX - Gastos De Venta Y Administración





Gastos De Venta Y Administración Cambio Fecha
Abbott USD 3.13B 125M 2025-12
Align Technology USD 441.68M 23.88M 2025-12
Anika Therapeutics USD 10.01M 14K 2025-12
Arrowhead Research USD 46.02M 8.84M 2025-12
Artivion USD 55.75M 4.54M 2025-12
Baxter International USD 761M 53M 2025-12
Boston Scientific USD 1.83B 93M 2025-12
EDAP TMS EUR 8.81M 1.57M 2025-09
Edwards Lifesciences USD 602.9M 88.3M 2025-12
Haemonetics USD 109.15M 7.54M 2025-12
Heron Therapeutics USD 23.74M 605K 2025-12
J&J USD 6.75B 831M 2025-12
Merit Medical Systems USD 114.83M 7.45M 2025-12
Mesa Laboratories USD 27.31M 380K 2024-09
Nektar Therapeutics USD -0.18 0.07 2024-09
Option Care Health USD 172.14M 33K 2025-12
Stryker USD 2.14B 150M 2025-12
Surmodics USD 14.58M 2.05M 2024-09
Trinity Biotech USD 6.19M 2.18M 2025-09